SIGA - SIGA Technologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
4.12
+0.01 (+0.24%)
At close: 3:55PM EDT
Stock chart is not supported by your current browser
Previous Close4.11
Open4.12
Bid0.00 x 0
Ask0.00 x 0
Day's Range4.12 - 4.20
52 Week Range1.90 - 4.30
Volume27,595
Avg. Volume46,793
Market Cap325.1M
Beta1.48
PE Ratio (TTM)-8.00
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube2 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (ACHN-US, ... Read more (Read more...)

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017
    Capital Cube4 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017

    Categories: Yahoo FinanceGet free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (ACHN-US, ... Read more (Read more...)

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube7 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc., Newlink Genetics Corporation and NanoViricides, ... Read more (Read more...)

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
    Capital Cube7 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc., Newlink Genetics Corporation and NanoViricides, ... Read more (Read more...)

  • TheStreet.com11 months ago

    PharmAthene Declares Special Cash Dividend

    The biodefense company on Thursday declared a special one-time cash dividend, a day after receiving final payment from Siga in connection with a drug license dispute.

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016
    Capital Cube11 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016

    Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Sarepta Therapeutics, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (SRPT-US, BCRX-US and NLNK-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)